Harshad KULKARNI - AB Science Head Statistics

All Insiders . France . 
Stock . AB Science SA . Stakeholders . Insider . Harshad KULKARNI
AB Stock  EUR 0.82  0.04  5.13%   

Insider

Harshad KULKARNI is Head Statistics of AB Science SA
Phone33 1 47 20 00 14
Webhttps://www.ab-science.com

AB Science Management Efficiency

The company has return on total asset (ROA) of (0.4329) % which means that it has lost $0.4329 on every $100 spent on assets. This is way below average. AB Science's management efficiency ratios could be used to measure how well AB Science manages its routine affairs as well as how well it operates its assets and liabilities.
AB Science SA has accumulated 14.44 M in total debt with debt to equity ratio (D/E) of 102.9, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. AB Science SA has a current ratio of 1.06, suggesting that it is in a questionable position to pay out its financial obligations in time and when they become due. Debt can assist AB Science until it has trouble settling it off, either with new capital or with free cash flow. So, AB Science's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like AB Science SA sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for AB Science to invest in growth at high rates of return. When we think about AB Science's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Pr StaelsGenfit
60
Laurent LevyNanobiotix SA
50
Sarah GaubertNanobiotix SA
N/A
Grgory MeiffrenAdocia
N/A
Stefanie MagnerGenfit
42
Pascal CaiseyGenfit
55
Jean FourniInnate Pharma
N/A
Marc BonnevilleInnate Pharma
63
Frederic MBAInnate Pharma
48
Olivier MBAAdocia
53
DVM MBAInnate Pharma
58
Odile BelzunceInnate Pharma
43
JeanChristophe MarcouxGenfit
46
Pr PrasadNanobiotix SA
78
Mondher MDInnate Pharma
65
Grard SoulaAdocia
78
Alessandro MDInnate Pharma
N/A
Brandon OwensNanobiotix SA
N/A
Alain DostieNanobiotix SA
N/A
Valrie DanaguezianAdocia
N/A
Bart RhijnNanobiotix SA
N/A
AB Science S.A., a pharmaceutical company, engages in the discovery, development, and commercialization of protein kinase inhibitors for use in human and veterinary medicines. AB Science S.A. was founded in 2001 and is headquartered in Paris, France. AB SCIENCE operates under Drug Manufacturers - Major classification in France and is traded on Paris Stock Exchange. It employs 123 people. AB Science SA (AB) is traded on Euronext Paris in France and employs 100 people.

Management Performance

Return On Asset-0.43

AB Science SA Leadership Team

Elected by the shareholders, the AB Science's board of directors comprises two types of representatives: AB Science inside directors who are chosen from within the company, and outside directors, selected externally and held independent of AB Science. The board's role is to monitor AB Science's management team and ensure that shareholders' interests are well served. AB Science's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, AB Science's outside directors are responsible for providing unbiased perspectives on the board's policies.
Harshad KULKARNI, Head Statistics
Alain MBA, Chairman, CoFounder
Yves MD, Head Pharmacovigilance
Laurent MBA, Chief Officer
Alexis BERNARD, Head Sales
Albert DVM, Pres Operations
Christian FASSOTTE, Global Officer

AB Science Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is AB Science a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Asset-0.43
Operating Margin(12.22) %
Current Valuation427.66 M
Shares Outstanding46.86 M
Shares Owned By Insiders41.25 %
Shares Owned By Institutions1.79 %
Price To Earning(10.99) X
Price To Sales193.66 X
Revenue1.61 M
Gross Profit1.5 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
VVisa Class A
GOOGAlphabet Inc Class C
GOOGAlphabet Inc Class C

Other Information on Investing in AB Science Stock

AB Science financial ratios help investors to determine whether AB Science Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in AB Science with respect to the benefits of owning AB Science security.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY